+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liquid Biopsy"

From
From
From
Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
From
Global Liquid Biopsy Market Outlook 2028 - Product Thumbnail Image

Global Liquid Biopsy Market Outlook 2028

  • Report
  • July 2021
  • 106 Pages
  • Global
From
From
From
Oncology Diagnostics in IVD Growth Opportunities - Product Thumbnail Image

Oncology Diagnostics in IVD Growth Opportunities

  • Report
  • July 2023
  • 145 Pages
  • Global
From
United States Liquid Biopsy Growth Opportunities - Product Thumbnail Image

United States Liquid Biopsy Growth Opportunities

  • Report
  • February 2022
  • 73 Pages
  • United States
From
From
Liquid Biopsy Global Market Report 2024 - Product Thumbnail Image

Liquid Biopsy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
UAE Minimally Invasive Biopsy Techniques Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

UAE Minimally Invasive Biopsy Techniques Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • February 2025
  • 85 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
Loading Indicator

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions. The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests. Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more